Company Overview of Perosphere Inc.
Perosphere Inc., a specialty pharmaceutical company, focuses on developing rescue medications. Its products include ciraparantag (PER977) is an intravenously administered small synthetic water soluble new molecular entity for use as a reversal agent for anticoagulants, including heparins, as well as direct oral anticoagulants, allowing re-establishment of a normal blood coagulation state when clinically indicated; and point-of-care coagulometer, a hand-held anticoagulant monitoring diagnostic device for measuring or monitoring the activity of anticoagulants and their corresponding reversal agents across various drug classes. The company’s products also comprise PER1080, a formulation of a th...
20 Kenosia Avenue
Danbury, CT 06810
Founded in 2011
Key Executives for Perosphere Inc.
Founder, Chairman, Chief Executive Officer and President
Founder, Chief Scientific Officer and Senior Executive Vice President
Founder and Senior Executive Vice President of Research
Founder and Member of Advisory Board
Chief Financial Officer, Executive Vice President of Finance and Treasurer
Compensation as of Fiscal Year 2016.
Perosphere Inc. Key Developments
Perosphere Inc. Receives FDA Fast Track Designation for Investigational Anticoagulant Reversal Agent PER977
Apr 2 15
Perosphere Inc. announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for PER977, an investigational anticoagulant reversal agent. The FDA established the Fast Track designation process to facilitate the development and expedite the review of drugs intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. An important feature of Fast Track is that the FDA may grant frequent and expedited interactions to discuss study design, extent of safety data required to support approval, dose-response concerns, and use of biomarkers. Fast Track also offers the opportunity for the FDA to consider a "rolling review" of completed sections of the New Drug Application (NDA) before the complete application is submitted.
Perosphere Inc. Presents at BIO-Europe Spring 2015, Mar-09-2015
Jan 29 15
Perosphere Inc. Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.
Perosphere Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015
Dec 24 14
Perosphere Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
October 8, 2015
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries